City of Chicago v. Purdue Pharma L.P. et al.
Case Number:
1:14-cv-04361
Court:
Nature of Suit:
Judge:
Firms
- Arnold & Porter
- Baker & Hostetler
- Baugher Dispute Resolution
- Benesch
- Burke Warren
- Cohen Milstein
- Covington & Burling
- Dechert LLP
- DiCello Levitt
- Dickinson Wright
- Duane Morris
- Faegre Drinker
- Foley & Lardner
- Hinshaw & Culbertson
- Hogan Lovells
- Holland & Knight
- Jenner & Block
- Jones Day
- Keller Rohrback
- King & Spalding
- Kirkland & Ellis
- K&L Gates
- Lanier Law Firm
- Law Offices of David J. Stetler
- Levin Papantonio
- Mayer Brown
- McCarter & English
- Miller Shakman
- Miner Barnhill
- Morgan Lewis
- Motley Rice
- O'Melveny & Myers
- Polsinelli PC
- Porter Hedges
- Proskauer Rose
- Quinn Emanuel
- Redgrave LLP
- Robbins Geller
- Ropes & Gray
- Seeger Weiss
- Sidley Austin
- Skadden Arps
- Skikos Crawford
- Stetler & Rotert
- Tressler LLP
- Tucker Ellis
- Wagstaff & Cartmell
- Wallace Miller
- Wexler Boley
- Wiggin & Dana
Companies
- AbbVie Inc.
- Allergan PLC
- Assertio Holdings Inc.
- Cephalon Inc.
- Endo International PLC
- Johnson & Johnson
- Los Angeles Times
- Mallinckrodt PLC
- Purdue Pharma LP
- Teva Pharmaceutical Industries Ltd.
- USA Today International Corp.
Government Agencies
Sectors & Industries:
-
November 19, 2019
Opioid MDL Judge Plots New Bellwether Trials Across US
The Ohio federal judge guiding multidistrict opioid litigation on Tuesday singled out numerous cases as good candidates for future bellwether trials, pitting a potpourri of plaintiffs against an assortment of drug companies.
-
November 16, 2017
Chicago's Suit Over Opioids Paused Ahead Of MDL Ruling
An Illinois federal judge on Thursday put a hold on the city of Chicago's lawsuit against a group of pharmaceutical companies over their alleged misrepresentation of opioid painkillers' addictiveness, saying it should wait until a decision is made on whether to consolidate similar claims in multidistrict litigation.
-
November 01, 2017
Janssen Must Fork Over More Employee Info In Opioid Suit
An Illinois federal judge on Wednesday partially granted the city of Chicago's bid to force pharmaceutical company Janssen to produce information related to marketing employees in the city's suit over the alleged misleading marketing of opioids, saying the company never explained exactly why producing the documents would be a burden.
-
October 31, 2017
Drugmakers Want Chicago's Opioid Suit Paused Pending MDL
Purdue Pharma, Janssen Pharmaceuticals and Cephalon Inc. on Monday asked an Illinois federal court to stay the city of Chicago's suit accusing them of deceptively marketing opioid painkillers until after the Judicial Panel on Multidistrict Litigation decides whether to consolidate more than 70 related suits.
-
October 18, 2017
Chicago Seeks Janssen Employees' Info In Opioid Suit
The city of Chicago on Tuesday told an Illinois federal judge that 10 Janssen employees likely have documents related to the city's claims that the drug company and others misleadingly marketed opioids and the city should be allowed to seek those documents.
-
June 30, 2017
Product Liability Cases To Watch: Midyear Report
Lawsuits over the ongoing opioid epidemic continue to mount, and litigation against carmakers alleging emissions violations is revving up just as Volkswagen is in the process of ending its own cases. Attorneys are also watching to see how Takata's long-expected bankruptcy will affect litigation over its potentially dangerous air bags.
-
January 30, 2017
Chicago Fights Latest Effort To Kill Opioid Addiction Suit
Chicago struck back last week at an attempt to deal the final blow to large portions of a federal lawsuit dinging pharmaceutical companies for overselling painkillers while hiding their addictive properties, accusing the companies of organizing a "blunderbuss" attack against the case by attempting to relitigate matters that have already been resolved.
-
December 16, 2016
Drug Cos. Say Chicago's Opioid Claims Still Miss The Mark
Drug companies on Thursday told an Illinois federal judge that the city of Chicago's suit accusing them of downplaying the addictive risks of opioid painkillers still fails to identify prescriptions that were ineffective or harmful, and that the city continues to reimburse prescriptions for chronic, non-cancer pain.
-
October 26, 2016
Chicago Says Drug Cos.' Opioids Forced Spending On Addicts
The city of Chicago took a last stab at updating its complaint in its suit against Janssen Pharmaceuticals Inc. and several other pharmaceutical companies over their alleged deceptive marketing of opioid painkillers Tuesday, adding details about the city's own fight against abuse of the addictive drugs.
-
September 29, 2016
Drug Cos. Lose Bid to Stay Chicago's Opioid Marketing Suit
Some of the nation's leading pharmaceutical companies on Thursday lost a bid to dodge consumer fraud claims from the city of Chicago over an alleged scheme to sell opiates despite their addictive properties, with an Illinois federal judge denying an attempt to stay the case pending FDA reviews.